TIDMRGT 
 
For immediate release 
25 June 2010 
 
                             ReGen Therapeutics Plc 
 
                                Issue of Equity 
 
 
ReGen  Therapeutics  Plc  ("ReGen"  or  the  "Company"), (AIM:RGT) is pleased to 
announce  that it has conditionally placed  5,000,000 new ordinary shares at 2p 
per ordinary share to raise  GBP100,000 before expenses for general working capital 
purposes. 
 
The  5,000,000 new ordinary  shares, which  will represent  7.51 per cent of the 
enlarged  issued  share  capital  of  the  Company  (in  aggregate  amounting to 
66,613,215 ordinary  shares on completion of the  placing), will rank pari passu 
in all respects with the existing ordinary shares in the Company. 
 
Application  has been  made to  the London  Stock Exchange  for the new ordinary 
shares to be admitted to trading on AIM and admission is expected to commence on 
or around Wednesday 30 June 2010. 
 
For further information, please contact: 
 
Percy Lomax 
ReGen Therapeutics Plc 
Tel: 020 7153 4920 
 
Roland Cornish/Felicity Geidt 
Beaumont Cornish Limited 
Tel: 020 7628 3396 
 
David Scott/Nick Bealer 
Alexander David Securities Limited 
Tel: 020 7448 9820 
 
ENDS 
 
 
[HUG#1427255] 
 
 
 
 
 
 
 
 
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. 
The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein. 
All reproduction for further distribution is prohibited. 
 
Source: ReGen Therapeutics Plc via Thomson Reuters ONE
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Argent Biopharma Charts.
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Argent Biopharma Charts.